TCL Archive A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs. April 21, 2006
TCL Archive In Brief: Durant To Retire From ASCO In A Year; Led Society Through Management Change July 24, 1998
TCL Archive Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial. March 1, 2002
TCL Archive “NIH Reveres, Honors, respects And Defends One And Only One Mechanisms’ – R01s September 20, 1991
TCL Archive In Brief: NCAB Approves Concept Of Converting Baltimore Program To Cancer Center; New DCCP Labs Named June 5, 1981
